Introduction Shijiazhuang Yiling Pharmaceutical is a company that specializes in the development, production, and sale of patented medicines. Their product range includes traditional medicines, healthcare products, western formulations, and TCM slices. The company also provides advanced equipment and pharmaceutical technology to both domestic and international markets and has established a robust quality control system. |
Top 5 Drug Type | Count |
---|---|
Herbal medicine | 21 |
Small molecule drug | 5 |
Monoclonal antibody | 1 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date19 Oct 2023 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. KE |
First Approval Date27 Jun 2023 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date14 Dec 2021 |
Start Date29 May 2024 |
Sponsor / Collaborator |
Start Date15 Apr 2024 |
Sponsor / Collaborator |
Start Date29 Mar 2024 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Tongluo Mingmu Capsules | Nonproliferative diabetic retinopathy More | Approved |
Lianhua Qingwen Capsule | Influenza, Human More | Approved |
Jieyu Chufan Capsule | Depressive Disorder More | Approved |
Yishen Yangxin Anshen Tablets | Sleep Initiation and Maintenance Disorders More | Approved |
QiLiqiangXin | Acute decompensated heart failure More | Approved |